Committee on Smallpox Vaccination Program, Implementation Board on Health Promotion and Disease Prevention, Institute of Medicine. Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation: Letter Report #3, 2003. This is a letter from the Institute of Medicine (IOM) dated 5/23/03 to Dr. Julie Gerberding, Director of CDC, which provides advice on implementation of the pre-event smallpox vaccination program. The letter recommends "a pause to evaluate." The reasons for the recommended pause are the following:
Safety: It is noted that through 4/29/03, only 34% of vaccinees were included in the Active Surveillance system. It was also noted that cardiac complications were unexpected and that there may be additional adverse effects.
Changing circumstances: There is concern that the educational materials need to be updated. For example, the Pre-Vaccination Information Packet has not been updated since 3/31/03.
Overall smallpox preparedness: The rationale here is to determine the required level of pre-event vaccination and what personnel should be vaccinated.
Medscape Infectious Diseases. 2003;5(2) © 2003 Medscape
Cite this: July 15, 2003 - Medscape - Jul 24, 2003.